Odonate Therapeutics

+$0.08 (+2.13%) Today
+$0.03 (+0.78%) As of 10:40 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ODT and other ETFs, options, and stocks.

About ODT

Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer.

CEO
Kevin C. Tang
Employees
153
Headquarters
New York, New York
Founded
2013

ODT Key Statistics

Market Cap
152.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
643.53K
High Today
$3.90
Low Today
$3.64
Open Price
$3.78
Volume
481.18K
52 Week High
$41.75
52 Week Low
$2.80

ODT Earnings

-$1.09
-$0.73
-$0.36
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure